PSIL vs. PBE ETF Comparison
Comparison of AdvisorShares Psychedelics ETF (PSIL) to PowerShares Dynamic Biotech & Genome (PBE)
PSIL
AdvisorShares Psychedelics ETF
PSIL Description
AdvisorShares Trust - AdvisorShares Psychedelics ETF is an exchange traded fund launched and managed by AdvisorShares Investments, LLC. The fund invests in public equity markets of global region. It invests directly and through derivatives in stocks of companies operating across healthcare, pharmaceuticals, biotechnology and life sciences companies focused on plant-based psychedelic medicines as well as other companies with business activities in the psychedelics industry sectors. The fund uses derivatives such as swaps to create its portfolio. It invests in growth and value stocks of companies across diversified market capitalization. The investment seeks long-term capital appreciation. AdvisorShares Trust - AdvisorShares Psychedelics ETF is domiciled in the United States.
Grade (RS Rating)
Last Trade
$11.87
Average Daily Volume
32,539
8
PBE
PowerShares Dynamic Biotech & Genome
PBE Description
The PowerShares Dynamic Biotechnology & Genome Portfolio (Fund) is based on the Dynamic Biotech & Genome IntellidexSM Index (Intellidex Index). The Fund will normally invest at least 90% of its total assets in common stocks that comprise the Index. The Intellidex Index is designed to provide capital appreciation by thoroughly evaluating companies based on a variety of investment merit criteria, including price momentum, earnings momentum, quality, management action, and value. The Underlying Intellidex Index is comprised of common stocks of 30 US biotechnology and genome companies. These are companies that are principally engaged in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes and companies that benefit significantly from scientific and technological advances biotechnology and genetic engineering and reseach. The Fund and the Index are rebalanced and reconstituted quarterly in February, May, August and November.Grade (RS Rating)
Last Trade
$68.40
Average Daily Volume
6,342
30
Performance
| Period | PSIL | PBE |
|---|---|---|
| 30 Days | -7.09% | -0.98% |
| 60 Days | 51.83% | -5.20% |
| 90 Days | 34.46% | -4.17% |
| 12 Months | -9.86% | 20.11% |
0 Overlapping Holdings
| Symbol | Grade | Weight in PSIL | Weight in PBE | Overlap |
|---|
PSIL Underweight 30 Positions Relative to PBE
| Symbol | Grade | Weight | |
|---|---|---|---|
| UTHR | C | -5.74% | |
| ILMN | C | -5.64% | |
| ALNY | D | -4.78% | |
| AMGN | D | -4.7% | |
| BIIB | F | -4.21% | |
| NBIX | C | -4.18% | |
| XNCR | B | -3.88% | |
| EXEL | B | -3.86% | |
| TGTX | B | -3.78% | |
| BMRN | F | -3.76% | |
| MNKD | B | -3.7% | |
| NTRA | A | -3.56% | |
| REGN | F | -3.38% | |
| INCY | C | -3.35% | |
| VCYT | B | -3.28% | |
| ACAD | C | -3.06% | |
| CPRX | C | -3.0% | |
| BPMC | C | -2.91% | |
| TECH | F | -2.89% | |
| VCEL | A | -2.79% | |
| OPK | B | -2.78% | |
| RGEN | D | -2.76% | |
| PTGX | D | -2.75% | |
| QGEN | D | -2.59% | |
| BCRX | D | -2.56% | |
| HALO | F | -2.42% | |
| COLL | F | -2.27% | |
| CDNA | D | -1.92% | |
| NVAX | F | -1.83% | |
| MYGN | F | -1.61% |
PSIL: Top Represented Industries & Keywords
PBE: Top Represented Industries & Keywords
Compare ETFs
